title: Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.
authors.affiliation: International Diabetes Center, Minneapolis, Minnesota.
authors.forename: Richard M
authors.initials: RM
authors.lastname: Bergenstal
authors.affiliation: Barbara Davis Center for Diabetes, University of Colorado Denver, Aurora.
authors.forename: Satish
authors.initials: S
authors.lastname: Garg
authors.affiliation: Yale University, New Haven, Connecticut.
authors.forename: Stuart A
authors.initials: SA
authors.lastname: Weinzimer
authors.affiliation: Stanford University, Stanford, California.
authors.forename: Bruce A
authors.initials: BA
authors.lastname: Buckingham
authors.affiliation: Atlanta Diabetes Associates, Atlanta, Georgia.
authors.forename: Bruce W
authors.initials: BW
authors.lastname: Bode
authors.affiliation: Yale University, New Haven, Connecticut.
authors.forename: William V
authors.initials: WV
authors.lastname: Tamborlane
authors.affiliation: Medtronic, Northridge, California.
authors.forename: Francine R
authors.initials: FR
authors.lastname: Kaufman
mesh_terms: D000465:Algorithms; D001786:Blood Glucose; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use*; D007332:Insulin Infusion Systems
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin